BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease


 

With Annual Growth of 31%, Biophotonics Market Zooms to $133 Billion by 2016!

 

New York, November 29, 2006 — The business of looking at biological functions at the cellular level or even smaller is big. Really big! Known as Biophotonics—a marriage of photon-based experimental manipulation and advanced optical imaging—the market is growing at approximately 31% annually with worldwide revenues reaching $11 billion in 2006.

According to Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications, the latest market research from Kalorama Information, the market will soar to $133 billion by 2016 as the techniques become more of a modus operandi in the fields of pharmaceutical discovery and development; molecular biology research, such as proteomics and genomics; histology/cytology research; and clinical research, including oncology and virology.

The market for biophotonics technology and products is part of the larger photonics and optoelectronics market, and interplay between the markets keeps the technology advancing at a fast pace. Report findings show that key to growth in biophotonic technology is its ability to augment and even replace many current technologies in research, in vitro diagnostics, imaging, and even therapeutics. The speed and performance of biophotonic approaches is expected to induce rapid replacement of existing products as well as technology upgrades to existing biophotonic systems.

“The market base for biophotonics is quite large, consisting of research laboratories in institutes, universities, industry and hospitals; clinical lab settings, both commercial and hospital; and hospital radiology settings,” notes Kenneth G. Krul, Ph.D., the report’s author. “The increased usage of biophotonics in these settings should result in increased levels of drug development activity, as well as making diagnostics, therapeutics, and imaging development more efficient and effective.”

Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications focuses on the technology of biophotonics, its applications to biomedical research, its potential for clinical applications, and the progress that is being made in these fields. It provides global forecasts and market analysis with a focus on the U.S., as well as profiles of major players in the field. It can be purchased directly from Kalorama Information by clicking

 

http://www.bioportfolio.com/cgi-bin/acatalog/Biophotonics_-_A_Strategic_Assessment_of_Photonics_Technologies_for_Biomedical_Applications.html


About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. To view their catalogue go to:

 

http://www.bioportfolio.com/cgi-bin/acatalog/Kalorama.html

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreements

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Stafford House, 10 Prince of Wales Road, Dorchester, Dorset, DT1 1PW, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.